Black Friday Deal: $15 OFF Forever on All Plans — Limited Time Only!
NXGN logo
NASDAQ · NXGNMedical - Healthcare Information ServicesUpdated Not supplied

NextGen Healthcare, Inc. P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

N/M

No meaningful positive P/E available.

Share price23.94
÷
Earnings per share-0.09

Price and EPS in quote currency. Calculation details

Zero or negative earnings do not produce a meaningful conventional P/E.

P/E over time

2014 – 2023
Annual P/ESelected-period average 221.42×
3-year average587.39×2 positive annual observations
5-year average328.48×4 positive annual observations
10-year average221.42×9 positive annual observations
Peer median · TTM28.41×2 peers with positive P/E

Historical P/E ratios

Annual period-end data · 25 observations

NXGN annual P/E history, newest first
Period endP/EChange
Mar 31, 2023N/MN/M
Mar 31, 20221045.50×+708.7%
Mar 31, 2021129.29×+36.2%
Mar 31, 202094.91×+114.7%
Mar 31, 201944.21×-87.7%
Mar 31, 2018358.27×+605.3%
Mar 31, 201750.80×-70.0%
Mar 31, 2016169.33×+376.8%
View all 25 annual observations +
NXGN annual P/E history, newest first
Period endP/EChange
Mar 31, 201535.51×-45.3%
Mar 31, 201464.92×+154.6%
Mar 31, 201325.50×-24.8%
Mar 31, 201233.90×-13.8%
Mar 31, 201139.31×+8.8%
Mar 31, 201036.14×+32.6%
Mar 31, 200927.26×+35.1%
Mar 31, 200820.18×-37.4%
Mar 31, 200732.26×-14.2%
Mar 31, 200637.61×+13.7%
Mar 31, 200533.08×+22.3%
Mar 31, 200427.04×+18.7%
Mar 31, 200322.78×+28.6%
Mar 31, 200217.72×-8.3%
Mar 31, 200119.31×-49.3%
Mar 31, 200038.13×-8.1%
Mar 31, 199941.48×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How NXGN compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with NXGN and provider-selected peers
CompanyP/E ratio
NXGN logo
NXGN This stockNextGen Healthcare, Inc.
N/M
AGTI logo
AGTIAgiliti, Inc.
N/M
TARO logo
TAROTaro Pharmaceutical Industries Ltd.
30.05×
VIVO logo
VIVOVivoPower PLC
N/M
ASTH logo
ASTHAstrana Health, Inc.
26.76×
AMAM logo
AMAMAmbrx Biopharma Inc.
N/M
HSKA logo
HSKAHeska Corporation
N/M
FUSN logo
FUSNFusion Pharmaceuticals Inc.
N/M
BLU logo
BLUBELLUS Health Inc.
N/M

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does NXGN’s P/E tell you?

01

Start with its own history

Compare positive annual observations to understand how this company has been priced over time. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 2 positive peer ratios above is 28.41×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take NXGN into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("NXGN", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

A conventional P/E is not meaningful when earnings are zero or negative. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

NXGN P/E ratio: common questions

The essentials behind the numbers.

NextGen Healthcare, Inc. does not currently have a meaningful positive P/E in the quote data. A zero or negative EPS makes the conventional P/E unsuitable for comparison.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.